Matrixyl 3000 10mg

For research purposes only, this product is not intended for human consumption, diagnosis, or treatment. It has not been approved by the FDA or MHRA. Sales are limited to qualified researchers and institutions, and misuse could lead to account termination or legal consequences.

Description & Mechanism
Matrixyl consists of a short pentapeptide sequence covalently modified at the N-terminus with a palmitoyl fatty acid chain. This lipid conjugation increases hydrophobicity and is used in research settings to study peptide–lipid interactions, peptide stability, and extracellular matrix–associated signalling processes in cellular and formulation-based systems.

In experimental models, Matrixyl is utilised as a reference compound for investigating matrikine-related signalling, peptide uptake dynamics, and the behaviour of lipid-modified peptides in dermal or fibroblast-associated research assays. Observed molecular responses are dependent on experimental design, concentration, formulation matrix, and model system.